FR2681326B1 - Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments. - Google Patents

Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.

Info

Publication number
FR2681326B1
FR2681326B1 FR9211432A FR9211432A FR2681326B1 FR 2681326 B1 FR2681326 B1 FR 2681326B1 FR 9211432 A FR9211432 A FR 9211432A FR 9211432 A FR9211432 A FR 9211432A FR 2681326 B1 FR2681326 B1 FR 2681326B1
Authority
FR
France
Prior art keywords
medicaments
preparation
peptide derivatives
novel peptide
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9211432A
Other languages
English (en)
Other versions
FR2681326A1 (fr
Inventor
Cardinaux Francois
Oechslein Christine
Rummelt Andreas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Solvay SA
Original Assignee
Solvay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay SA filed Critical Solvay SA
Publication of FR2681326A1 publication Critical patent/FR2681326A1/fr
Application granted granted Critical
Publication of FR2681326B1 publication Critical patent/FR2681326B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
FR9211432A 1990-09-20 1992-09-22 Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments. Expired - Fee Related FR2681326B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909020544A GB9020544D0 (en) 1990-09-20 1990-09-20 Improvements in or relating to organic compounds

Publications (2)

Publication Number Publication Date
FR2681326A1 FR2681326A1 (fr) 1993-03-19
FR2681326B1 true FR2681326B1 (fr) 1995-06-16

Family

ID=10682494

Family Applications (2)

Application Number Title Priority Date Filing Date
FR9111537A Pending FR2666987A1 (fr) 1990-09-20 1991-09-17 Nouvelle composition pour l'administration par voie nasale.
FR9211432A Expired - Fee Related FR2681326B1 (fr) 1990-09-20 1992-09-22 Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR9111537A Pending FR2666987A1 (fr) 1990-09-20 1991-09-17 Nouvelle composition pour l'administration par voie nasale.

Country Status (21)

Country Link
US (1) US5578567A (fr)
EP (2) EP0672682A1 (fr)
JP (1) JPH04247034A (fr)
KR (1) KR920006003A (fr)
AT (1) ATA189691A (fr)
AU (1) AU8464791A (fr)
CA (1) CA2051721A1 (fr)
CH (1) CH683749A5 (fr)
CS (1) CS285491A3 (fr)
DE (1) DE4131232A1 (fr)
FI (1) FI914398A (fr)
FR (2) FR2666987A1 (fr)
GB (2) GB9020544D0 (fr)
IE (1) IE913296A1 (fr)
IL (1) IL99521A0 (fr)
IT (1) IT1255258B (fr)
LU (1) LU88006A1 (fr)
MX (1) MX9101175A (fr)
NO (1) NO913668D0 (fr)
PT (1) PT99007A (fr)
ZA (1) ZA917528B (fr)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3090353B2 (ja) * 1991-09-17 2000-09-18 旭化成工業株式会社 パラチロイドホルモン類含有経鼻投与用乳剤
US5563122A (en) * 1991-12-09 1996-10-08 Asahi Kasei Kogyo Kabushiki Kaisha Stabilized parathyroid hormone composition
DE4203040A1 (de) * 1992-02-04 1993-08-05 Boehringer Mannheim Gmbh Neue parathormonfragmente, deren herstellung und diese enthaltende arzneimittel
US5482706A (en) * 1992-04-17 1996-01-09 Takeda Chemical Industries, Ltd. Transmucosal therapeutic composition
US5977070A (en) * 1992-07-14 1999-11-02 Piazza; Christin Teresa Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
AU672790B2 (en) * 1992-07-15 1996-10-17 Novartis Ag Variants of parathyroid hormone and its fragments
GB2269992A (en) * 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
EP0679088B1 (fr) * 1992-09-29 2002-07-10 Inhale Therapeutic Systems Liberation dans les poumons de fragments actifs d'hormone parathyroidienne
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5496801A (en) * 1993-12-23 1996-03-05 Allelix Biopharmaceuticals Inc. Parathyroid hormone formulation
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
EP0806945B1 (fr) * 1994-12-22 2003-04-23 AstraZeneca AB Preparation therapeutique a inhaler contenant de l'hormone parathyroidienne, hpt
JP3098401B2 (ja) * 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
JP3263598B2 (ja) * 1995-11-01 2002-03-04 有限会社ドット 経鼻吸収用生理活性ペプチド組成物
EP0813887A3 (fr) * 1996-06-20 1999-11-03 Hisamitsu Pharmaceutical Co. Inc. Appareil d'ionophorèse
TW505654B (en) 1996-07-30 2002-10-11 Hoffmann La Roche Synthesis of analogs of PTH and PTHrP
SE9702401D0 (sv) 1997-06-19 1997-06-19 Astra Ab Pharmaceutical use
EP1016412A4 (fr) * 1997-07-22 2001-05-02 Chugai Pharmaceutical Co Ltd Medicaments dentaires contenant de la pth
US7923250B2 (en) 1997-07-30 2011-04-12 Warsaw Orthopedic, Inc. Methods of expressing LIM mineralization protein in non-osseous cells
US6300127B1 (en) 1997-07-30 2001-10-09 Emory University Bone mineralization proteins, DNA, vectors, expression systems
US6770623B1 (en) 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
MY120063A (en) † 1997-12-09 2005-08-30 Lilly Co Eli Stabilized teriparatide solutions
DE19756314C2 (de) * 1997-12-12 2000-06-29 Roland Bodmeier Zubereitung mit verlängerter Verweildauer am Applikationsort
JPH11246439A (ja) * 1998-03-02 1999-09-14 Hisamitsu Pharmaceut Co Inc 経粘膜用吸収促進剤
AU3055099A (en) * 1998-05-20 1999-12-06 Charna Chemicals Ltd. A pharmaceutical formulation for nasal administration
CN1065141C (zh) * 1998-05-20 2001-05-02 北京金源东和化学有限责任公司 通过鼻粘膜给药的药物制剂
US6150420A (en) * 1998-06-01 2000-11-21 Theramax, Inc. Method for enhanced brain delivery of bupropion
ATE331532T1 (de) * 1998-08-26 2006-07-15 Teijin Ltd Pulverförmige pernasale mittel
JP2000239187A (ja) * 1999-02-22 2000-09-05 Dotto:Kk 経鼻吸収用組成物
JP2000247911A (ja) 1999-02-26 2000-09-12 Hisamitsu Pharmaceut Co Inc 大腸用吸収促進剤
JP2002543165A (ja) * 1999-05-03 2002-12-17 バテル・メモリアル・インスティテュート エーロゾル化および吸入のための組成物
US6197328B1 (en) * 1999-08-20 2001-03-06 Dott Research Laboratory Nasally administrable compositions
ES2166278B2 (es) * 1999-09-14 2003-06-16 Univ Madrid Complutense Procedimiento de preparacion de polvos nasales por atomizacion utilizando excipientes insolubles y absorbentes como promotores de absorcion nasal.
WO2001074431A2 (fr) * 2000-04-03 2001-10-11 Battelle Memorial Institute Dispositifs et formulations
EP1297842A4 (fr) 2000-06-30 2005-03-30 Daiichi Suntory Pharma Co Ltd Constituants medicinaux comportant de l'hormone parathyroidienne humaine et compositions medicinales pour l'administration nasale contenant lesdits constituants
JP2004526674A (ja) * 2000-12-01 2004-09-02 バテル・メモリアル・インスティテュート 液体処方物中における生体分子の安定化のための方法
DE10120200B4 (de) * 2001-04-24 2005-12-22 Infood Gmbh Schnupfpulver als Schnupftabakersatz
JP2005531570A (ja) * 2002-05-23 2005-10-20 ユーエムディー， インコーポレイテッド 貫粘膜薬物送達及び凍結保護のための組成物及び方法
US7273889B2 (en) * 2002-09-25 2007-09-25 Innovative Drug Delivery Systems, Inc. NMDA receptor antagonist formulation with reduced neurotoxicity
AU2003282955A1 (en) * 2002-10-17 2004-05-04 Alkermes Controlled Therapeutics, Inc. Ii Microencapsulation and sustained release of biologically active polypeptides
GB0304636D0 (en) * 2003-02-28 2003-04-02 Britannia Pharmaceuticals Ltd Pharmaceutical composition for nasal delivery
US7683029B2 (en) * 2003-05-07 2010-03-23 Philip Morris Usa Inc. Liquid aerosol formulations containing insulin and aerosol generating devices and methods for generating aerosolized insulin
US20060052305A1 (en) * 2004-05-10 2006-03-09 Nastech Pharmaceutical Company Inc. Method of treating osteoporosis using intranasal parathyroid hormone
RU2006143544A (ru) 2004-05-10 2008-06-20 Нэстек Фармасьютикал Кампани Инк. (Us) Композиции и способ для облегченной чресслизистой доставки паратиреоидного гормона
US20060052306A1 (en) * 2004-05-10 2006-03-09 Nastech Pharmaceutical Company Inc. GRAS composition for enhanced mucosal delivery of parathyroid hormone
US20060189533A1 (en) * 2004-05-10 2006-08-24 Nastech Pharmaceutical Company Inc. Stable pharmaceutical dosage forms of teriparatide
US20060127320A1 (en) * 2004-05-10 2006-06-15 Nastech Pharmaceutical Company Inc. Method of delivering parathyroid hormone to a human
US7906137B2 (en) * 2004-05-21 2011-03-15 Mediplex Corporation, Korea Delivery agents for enhancing mucosal absorption of therapeutic agents
CA2573309A1 (fr) * 2004-07-14 2006-01-19 Chugai Seiyaku Kabushiki Kaisha Agent d'administration transmucosale contenant une hormone parathyroide
US20060069021A1 (en) * 2004-08-13 2006-03-30 Nastech Pharmaceutical Company Inc. Compositions and methods for intranasal administration of inactive analogs of PTH or inactivated preparations of PTH or PTH analogs
US7115561B2 (en) * 2004-09-22 2006-10-03 Patterson James A Medicament composition and method of administration
US20090136505A1 (en) 2005-02-23 2009-05-28 Johanna Bentz Intranasal Administration of Active Agents to the Central Nervous System
CN101184499B (zh) * 2005-02-23 2012-03-28 阿尔扎公司 活性剂向中枢神经***的鼻内施用
WO2006135930A2 (fr) * 2005-06-13 2006-12-21 Nastech Pharmaceutical Company Inc. Administration transmucosale de dérivés peptidiques
WO2007044375A2 (fr) * 2005-10-06 2007-04-19 Nastech Pharmaceutical Company Inc. Formulations pth et procédés d'utilisation
AU2006299887A1 (en) * 2005-10-06 2007-04-19 Nastech Pharmaceutical Company Inc. PTH formulations and methods of use
US20070173447A1 (en) * 2005-10-25 2007-07-26 Nastech Pharmaceutical Company Inc. Method for treating osteoporosis by intranasal delivery of teriparatide with an anti-resorptive agent
CA2628945A1 (fr) 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Parathormone de l'ours noir et procedes d'utilisation de la parathormone de l'ours noir
US20080051332A1 (en) * 2005-11-18 2008-02-28 Nastech Pharmaceutical Company Inc. Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone
US20080119408A1 (en) * 2006-07-07 2008-05-22 Nastech Pharmaceutical Company Inc. Pth formulations for intranasal delivery
WO2008065144A2 (fr) * 2006-11-29 2008-06-05 Novartis Ag Préparations galéniques de composés organiques
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
EP2106788A1 (fr) * 2008-04-04 2009-10-07 Ipsen Pharma Formulations liquides et lyophilisées
WO2011071480A1 (fr) 2009-12-07 2011-06-16 Michigan Technological University Hormone parathyroïde de l'ours noir et ses procédés d'utilisation
CA2792749C (fr) * 2010-03-19 2016-08-23 Daiichi Sankyo Company, Limited Composition pour administration transnasale et sa methode de production
US10723716B2 (en) 2016-12-21 2020-07-28 New York University Alpha-helix mimetics as modulators of Abeta self-assembly
US11124479B2 (en) 2017-07-14 2021-09-21 New York University Oligopyrroles as antagonists of islet amyloid polypeptide oligomerization
US10500197B2 (en) 2017-07-18 2019-12-10 New York University Use of oligopyridylamides to inhibit mutant p53 amyloid formation and restore its tumor suppressor function
WO2021229835A1 (fr) * 2020-05-11 2021-11-18 旭化成ファーマ株式会社 Préparation pharmaceutique liquide stable contenant du tériparatide ou un sel de celui-ci
EP4281041A1 (fr) * 2021-01-21 2023-11-29 NBO Pharma LLC Formulations intranasales et administration de mimétiques de somatostatine et leurs utilisations

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3243358A1 (de) * 1982-11-24 1984-05-24 Rolf Dieter Prof.Dr. 3004 Isernhagen Hesch Synthetisches humanes (1-38) parathormon-fragment, verfahren zu seiner herstellung und die verwendung zur behandlung der osteoporose
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
FR2550204B1 (fr) * 1983-08-05 1987-11-13 Toyo Jozo Kk Derives peptidiques de (nle8,nle1b, tyr34)-h-pth
GB2193891B (en) * 1986-08-18 1990-07-25 Sandoz Ltd Nasal pharmaceutical composition containing a somatostatin anologue.
JPS6360940A (ja) * 1986-09-01 1988-03-17 Toyo Jozo Co Ltd 白内障の予防または治療剤
JPS63243033A (ja) * 1987-03-31 1988-10-07 Toyo Jozo Co Ltd 経鼻投与組成物
US5059587A (en) * 1987-08-03 1991-10-22 Toyo Jozo Company, Ltd. Physiologically active peptide composition for nasal administration
DE3886880T2 (de) * 1987-10-15 1994-07-14 Syntex Inc Pulverförmige Zubereitungen zur intranasalen Verabreichung von Polypeptiden.
EP0327756B1 (fr) * 1987-11-13 1994-01-26 Smithkline Beecham Farmaceutici S.p.A. Compositions pharmaceutiques contenant une calcitonine et un glycyrrhizinate comme promoteur d'absoption
JPH0242027A (ja) * 1988-08-02 1990-02-13 Minofuaagen Seiyaku Honpo:Goushi 経粘膜吸収促進剤及びこれを用いた経鼻投与剤
JPH02104531A (ja) * 1988-10-14 1990-04-17 Toyo Jozo Co Ltd 経鼻投与用生理活性ペプチド組成物
US5190748A (en) * 1988-11-22 1993-03-02 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
US5011678A (en) * 1989-02-01 1991-04-30 California Biotechnology Inc. Composition and method for administration of pharmaceutically active substances
AU647735B2 (en) * 1989-03-08 1994-03-31 University Of Virginia Alumni Patents Foundation, The Dietary supplement for insulin-resistant diabetics
IT8920486A0 (it) * 1989-05-12 1989-05-12 Isf Spa Composizioni farmaceutiche.
DE4039656A1 (de) * 1990-12-12 1992-06-17 Bissendorf Peptide Gmbh Arzneimittel, enthaltend das humane parathormon-fragment (1-37) in der form des amids oder ethylamids als aktiven wirkstoff
US5317010A (en) * 1991-10-10 1994-05-31 Peter K. T. Pang Parathyroid hormone analogues substituted at AA 25, 26, 27, and use in osteoporosis treatment

Also Published As

Publication number Publication date
US5578567A (en) 1996-11-26
NO913668D0 (no) 1991-09-18
GB9120024D0 (en) 1991-11-06
CH683749A5 (de) 1994-05-13
GB9020544D0 (en) 1990-10-31
GB2248550A (en) 1992-04-15
ATA189691A (de) 1997-10-15
DE4131232A1 (de) 1992-03-26
KR920006003A (ko) 1992-04-27
FR2666987A1 (fr) 1992-03-27
EP0672682A1 (fr) 1995-09-20
ITRM910696A0 (it) 1991-09-18
FI914398A0 (fi) 1991-09-18
ITRM910696A1 (it) 1993-03-18
ZA917528B (en) 1993-03-22
PT99007A (pt) 1992-08-31
CA2051721A1 (fr) 1992-03-21
JPH04247034A (ja) 1992-09-03
IL99521A0 (en) 1992-08-18
AU8464791A (en) 1992-03-26
EP0490806A2 (fr) 1992-06-17
LU88006A1 (fr) 1993-04-15
GB2248550B (en) 1995-04-05
MX9101175A (es) 1992-05-04
CS285491A3 (en) 1992-04-15
FI914398A (fi) 1992-03-21
FR2681326A1 (fr) 1993-03-19
IT1255258B (it) 1995-10-20
EP0490806A3 (en) 1992-09-23
IE913296A1 (en) 1992-02-25

Similar Documents

Publication Publication Date Title
FR2681326B1 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.
FR2629825B1 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments
FR2542000B1 (fr) Nouveaux derives de l'ethanol, leur preparation et leur utilisation comme fongicides
FR2561651B1 (fr) Nouveaux derives de la cyclosporine, leur preparation et leur utilisation comme medicaments
FR2531083B1 (fr) Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
FR2535321B1 (fr) Nouveaux derives de l'ethanol, leur preparation et leur utilisation comme fongicides
FR2501199B1 (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments
FR2711989B1 (fr) Nouvelles isoquinoléines, leur préparation et leur utilisation comme médicaments.
FR2590902B1 (fr) Nouveaux derives de la calcitonine, leur preparation et leur utilisation comme medicaments
FR2498188B1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
FR2625743B1 (fr) Derives d'isoquinoleine, leur preparation et leur utilisation
FI913476A (fi) Konjugatvacciner innehaollande immunogent protein, peptider av hiv-typ och anjoniska grupper.
MA20345A1 (fr) Nouveaux derives du cyano-2 benzimidazole,leur preparation et leur utilisation comme fongicides .
FR2617171B1 (fr) Nouveaux derives de la somatostatine, leur preparation et leur utilisation comme medicaments
FR2531962B1 (fr) Nouveaux derives de la desoxyuridine, leur preparation et leur utilisation comme medicaments
FR2551438B1 (fr) Nouveaux derives de l'ethanol, leur preparation et leur utilisation comme fongicides
FR2540112B1 (fr) Nouveaux derives de la benzo(g)quinoleine, leur preparation et leur utilisation comme medicaments
FR2675511B1 (fr) Nouveaux pigments, leur preparation et leur utilisation.
FR2686605B1 (fr) Nouveaux polypeptides, leur preparation et leur utilisation.
FR2691157B1 (fr) Nouveaux composes disazouiques, leur preparation et leur utilisation comme colorants.
FR2640271B1 (fr) Nouveaux derives de l'adenosine, leur preparation et leur utilisation comme medicaments
FR2549058B1 (fr) Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
FR2596051B1 (fr) Nouveaux derives de la purine, leur preparation et leur utilisation comme medicaments
FR2528431B1 (fr) Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
FR2532308B1 (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse